AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimigraf M 1 mg/500 mg Tablet

Prescription Icon
Prescription Required

Marketer

GRAF Laboratories Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimigraf M 1 mg/500 mg Tablet

DiaBeta Duo 1 mg/500 mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Administer DiaBeta Duo with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. DiaBeta Duo is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight control as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular meals, carry a fast-acting glucose source (e.g., sugary snacks or juice), and avoid alcohol to mitigate this risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. DiaBeta Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Disclose any history of heart disease to your doctor prior to use. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (to check blood cell counts and liver function) are recommended.

Primary Ingredients of Glimigraf M 1 mg/500 mg Tablet

No text was provided to rewrite.

Uses of Glimigraf M 1 mg/500 mg Tablet

Managing type 2 diabetes

Major Benefits of Glimigraf M 1 mg/500 mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimigraf M 1 mg/500 mg tablets should be administered with a meal.

Common Side effects of Glimigraf M 1 mg/500 mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimigraf M 1 mg/500 mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimigraf M 1 mg/500 mg Tablet with a meal.

How Glimigraf M 1 mg/500 mg Tablet works:

Glimigraf M, a 1 mg/500 mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Glimigraf M 1 mg/500 mg tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimigraf M 1 mg/500 mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Lactation and Glimigraf M 1 mg/500 mg tablets are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimigraf M 1 mg/500 mg tablets, as dose modification may be necessary. Severe kidney disease contraindicates the use of Glimigraf M 1 mg/500 mg tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver disease should use Glimigraf M 1 mg/500 mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. A low initial dose is typically recommended for those with mild to moderate liver impairment; however, its use is contraindicated in patients with severe liver disease.

What if you forget to take Glimigraf M 1 mg/500 mg Tablet :

Should you forget a Glimigraf M 1 mg/500 mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimigraf M 1 mg/500 mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimigraf M 1 mg/500 mg Tablet

Store this medication in its original, tightly closed container, following the instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimigraf M 1 mg/500 mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue use and seek immediate medical attention.
Glimigraf M 1 mg/500 mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimigraf M 1 mg/500 mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimigraf M 1 mg/500 mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Glimigraf M 1 mg/500 mg Tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed or delayed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimigraf M 1 mg/500 mg Tablet with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimigraf M 1 mg/500 mg T...
27
MRP 33
18% off